Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content
5f11ab56-2450-4a0a-815b-995e132ba66c_4_5005_c

Affiliation

The Royal Marsden NHS Foundation Trust

Country

United Kingdom

Current Status, Position

Mr Richard Nuttall is the Lead Electronic Chemotherapy Prescribing Pharmacist at the Royal Marsden Hospital in London. He is also the national lead for dose banding chemotherapy for NHS England.

Education

Mr Nuttall studied pharmacy at the Central Institute of Technology in Wellington (NZ) and completed the Certificate in Pharmacy Practice and the Paediatric Practice Module from the School of Pharmacy in London. He also completed the Mary Seacole Leadership programme from the NHS England Leadership Academy.

Research Area

Mr Nuttall helped develop the Royal Marsden Hospital’s electronic chemotherapy prescribing system and works closely with the clinical trials team and specialist haemato-oncology pharmacists to develop chemotherapy protocols. He led the development of a system for dose banding chemotherapy that has been adopted across NHS England and now leads the team responsible for maintaining this.

Conflict of interest: none

×